文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症患者肠道细菌群与真菌群均与28天死亡率相关

Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients.
PubMed 文献 · Crit Care · 2022-04-13
一句话结论重症患者入ICU时直肠拭子肠道细菌群和真菌群α多样性降低与28天死亡率独立相关(细菌群OR 0.19,真菌群OR 0.29)。

该研究在2019年10月至11月连续纳入57例ICU患者,入ICU时采集直肠拭子冻存于-80°C,通过16SRNA V3-V4区和ITS2基因PCR扩增及MiSeq测序分析肠道细菌群和真菌群组成,用logistic回归分析28天死亡危险因素。结果13/57(23%)死亡,44/57(77%)存活;非存活者细菌群α多样性(Shannon p<0.001,Simpson p=0.001)和真菌群α多样性(Shannon p=0.03,Simpson p=0.03)均低于存活者。多因素分析显示细菌群Shannon指数(OR 0.19,97.5 CI [0.04-0.60],p<0.01)和真菌群Shannon指数(OR 0.29,97.5 CI [0.09-0.75],p=0.02)均与28天死亡率独立相关。细菌群β多样性在存活者与非存活者间差异有统计学意义(p=0.05),真菌群β多样性无显著差异(p=0.57)。

要点

  • 57例ICU患者中13例(23%)28天死亡,44例(77%)存活。
  • 非存活者细菌群α多样性低于存活者:Shannon指数p<0.001,Simpson指数p=0.001。
  • 非存活者真菌群α多样性低于存活者:Shannon指数p=0.03,Simpson指数p=0.03。
  • 多因素分析:细菌群Shannon指数OR 0.19(97.5 CI [0.04-0.60],p<0.01),真菌群Shannon指数OR 0.29(97.5 CI [0.09-0.75],p=0.02),均与28天死亡率独立相关。
  • 细菌群β多样性在存活者与非存活者间差异有统计学意义(p=0.05),真菌群β多样性无显著差异(p=0.57)。

适用人群与场景

  • 2019年10月至11月连续收入ICU的所有患者,入ICU时采集直肠拭子。

研究设计与关键结果

  • 研究类型:在ICU患者中评估肠道菌群组成与28天死亡率关联的研究;连续纳入57例ICU患者,13/57(23%)死亡,44/57(77%)存活。
  • 入ICU时直肠拭子冻存于-80°C,QIAamp® PowerFecal® Pro DNA试剂盒提取DNA,PCR扩增16SRNA V3-V4区和ITS2编码基因,MiSeq测序仪(Illumina®)2x250 bp双端测序,R软件DADA2流程分析,logistic回归分析28天死亡危险因素。
  • 细菌群α多样性:非存活者低于存活者,Shannon指数p<0.001,Simpson指数p=0.001。
  • 真菌群α多样性:非存活者低于存活者,Shannon指数p=0.03,Simpson指数p=0.03。
  • 多因素分析:细菌群Shannon指数与28天死亡率独立相关(OR 0.19,97.5 CI [0.04-0.60],p<0.01);真菌群Shannon指数与28天死亡率独立相关(OR 0.29,97.5 CI [0.09-0.75],p=0.02)。
  • 细菌群β多样性在存活者与非存活者间差异有统计学意义(p=0.05);真菌群β多样性在两组间无显著差异(p=0.57)。
  • 非存活者中丰度较高的菌种:溶血性葡萄球菌(Staphylococcus haemolyticus)、梭菌目sp.(Clostridiales sp.)、解脲弯曲杆菌(Campylobacter ureolyticus)、阿克曼菌sp.(Akkermansia sp.)、对称梅拉色菌(Malassezia sympodialis)、皮肤梅拉色菌(Malassezia dermatis)、酿酒酵母(Saccharomyces cerevisiae)。
  • 存活者中丰度较高的菌种:柯林斯菌(Collinsella aerofaciens)、布劳特菌sp.(Blautia sp.)、链球菌sp.(Streptococcus sp.)、普拉梭菌(Faecalibacterium prausnitzii)、双歧杆菌sp.(Bifidobacterium sp.)。

证据类型、等级与局限

  • 证据类型:在ICU患者中开展的观察性研究(连续纳入57例,单次直肠拭子采样)。
  • 局限:原文未报告局限性;作者在结论中提出肠道菌群干扰的因果性质及潜在机制需进一步研究。

对床旁实践的改变

  • 作者认为肠道细菌群和真菌群α多样性与重症患者28天死亡率独立相关,其因果性质及机制需进一步研究,以评估肠道菌群调节是否可作为未来治疗手段。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Gut microbiota is associated with host characteristics such as age, sex, immune condition or frailty and is thought to be a key player in numerous human diseases. Nevertheless, its association with outcome in critically ill patients has been poorly investigated. The aim of this study is to assess the association between gut microbiota composition and Day-28 mortality in critically ill patients.

METHODS: Rectal swab at admission of every patient admitted to intensive care unit (ICU) between October and November 2019 was frozen at - 80 °C. DNA extraction was performed thanks to QIAamp® PowerFecal® Pro DNA kit (QIAgen®). V3-V4 regions of 16SRNA and ITS2 coding genes were amplified by PCR. Sequencing (2x250 bp paired-end) was performed on MiSeq sequencer (Illumina®). DADA2 pipeline on R software was used for bioinformatics analyses. Risk factors for Day-28 mortality were investigated by logistic regression.

RESULTS: Fifty-seven patients were consecutively admitted to ICU of whom 13/57 (23%) deceased and 44/57 (77%) survived. Bacteriobiota α-diversity was lower among non-survivors than survivors (Shannon and Simpson index respectively, p < 0.001 and p = 0.001) as was mycobiota α-diversity (respectively p = 0.03 and p = 0.03). Both gut bacteriobiota and mycobiota Shannon index were independently associated with Day-28 mortality in multivariate analysis (respectively OR: 0.19, 97.5 CI [0.04-0.60], p < 0.01 and OR: 0.29, 97.5 CI [0.09-0.75], p = 0.02). Bacteriobiota β-diversity was significantly different between survivors and non-survivors (p = 0.05) but not mycobiota β-diversity (p = 0.57). Non-survivors had a higher abundance of Staphylococcus haemolyticus, Clostridiales sp., Campylobacter ureolyticus, Akkermansia sp., Malassezia sympodialis, Malassezia dermatis and Saccharomyces cerevisiae, whereas survivors had a higher abundance of Collinsella aerofaciens, Blautia sp., Streptococcus sp., Faecalibacterium prausnitzii and Bifidobacterium sp.

CONCLUSION: The gut bacteriobiota and mycobiota α diversities are independently associated with Day-28 mortality in critically ill patients. The causal nature of this interference and, if so, the underlying mechanisms should be further investigated to assess if gut microbiota modulation could be a future therapeutic approach.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Prevel R, Enaud R, Orieux A, et al. Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients. Crit Care. 2022. PMID: 35418098. doi:10.1186/s13054-022-03980-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。